Travis B. Nielsen

University of Southern California — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index2.8kcitations55works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotic Resistance in Bacteria(15), Vibrio bacteria research studies(9), Immune Response and Inflammation(6), Antibiotic Use and Resistance(6), Escherichia coli research studies(4)

Publications55 total

Evaluating antibody mediated opsonophagocytosis of bacteria via lab protocol: RAW 264.7 cell phagocytosis assay
PLoS ONE·2025· 1 citedOpen Access
Practicing With Intent: How to Teach an Old Dogma New Tricks
Clinical Infectious Diseases·2025· 1 citedOpen Access
RAW 264.7 cell phagocytosis assay v1
2025Open Access
Restoring cefepime activity against multidrug-resistant KPC-producing <i>Klebsiella pneumoniae</i> by combination with boronic acid inhibitors, MB076 and S02030
Antimicrobial Agents and Chemotherapy·2025· 2 citedOpen Access
Sustainable solutions to the continuous threat of antimicrobial resistance
Health Affairs Scholar·2025· 10 citedOpen Access
A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens
Science Translational Medicine·2023· 34 citedOpen Access
Development of a Bispecific Antibody Targeting Clinical Isolates of <i>Acinetobacter baumannii</i>
The Journal of Infectious Diseases·2023· 19 citedOpen Access
Introducing antimicrobial stewardship to the outpatient clinics of a suburban academic health system
Antimicrobial Stewardship & Healthcare Epidemiology·2022· 3 citedOpen Access
Monoclonal Antibody Therapy against <i>Acinetobacter baumannii</i>
Infection and Immunity·2021· 41 citedOpen Access
Monoclonal Antibody Requires Immunomodulation for Efficacy Against <i>Acinetobacter baumannii</i> Infection
The Journal of Infectious Diseases·2021· 23 citedOpen Access
Capsule carbohydrate structure determines virulence in Acinetobacter baumannii
PLoS Pathogens·2021· 101 citedOpen Access
Introducing Antimicrobial Stewardship to the Outpatient Setting
Loyola eCommons (Loyola University of Chicago)·2021
Antibodies, Immunity, and COVID-19
JAMA Internal Medicine·2020· 49 citedOpen Access
142. Implementing an Antimicrobial Stewardship Program in the Outpatient Setting
Open Forum Infectious Diseases·2020· 1 citedOpen Access
A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii
Nature Microbiology·2020· 72 citedOpen Access
Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board
Annals of Internal Medicine·2019· 8 citedOpen Access
971. The Role of Inflammation and Innate Effectors in Passive Immunization for Acinetobacter baumannii Infections
Open Forum Infectious Diseases·2019Open Access
Natural history of Acinetobacter baumannii infection in mice
PLoS ONE·2019· 43 citedOpen Access
Sustainable Discovery and Development of Antibiotics — Is a Nonprofit Approach the Future?
New England Journal of Medicine·2019· 75 cited
Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition
PLoS ONE·2019· 17 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Brad Spellberg(33), Brian Luna(21), Jun Yan(17), Paul Pantapalangkoor(13), Robert A. Bonomo(12), Kevin W. Bruhn(8), Yuli Talyansky(5), Amber Ulhaq(5), Matthew Slarve(5), Brandon Tan(4), Kristine M. Hujer(4), Peggy Lu(4), Florence M. Rollwagen(4), Pramod M. Lad(3), M S Preston(3), Martin Rodbell(3), Justin L. Junus(3), Ken Dekitani(3), David N. Gilbert(3), Eric P. Skaar(3)